IPO Price Range: ₹25 - 25
Min Investment
₹1,50,000
IPO Size
₹4 Cr
IPO Status
Quantity in 1 Lot
6000
Max Bid allowed
1
Listing Exchange
BSE
Bid Opening Date | 13 Aug 2024 |
Bid Closing Date | 16 Aug 2024 |
Allotment Date | 19 Aug 2024 |
Issue Size | ₹4.02Cr |
Quantity in 1 lot | 6000 |
Clinical Excellence and Affordable Healthcare.
Strategic location.
Strong empanelment.
Ability to attract and retain high quality doctors, consultants and medical support staff.
Experienced Promoters, management team with a strong execution track record.
The Company has been formed specifically for the purpose of acquisition of the business of Dr. Vyass Hospital (proprietorship concern of its Promoter i.e., Dr. Jaykumar Narendra Vyas) thus the company has limited operating history as a Company which may make it difficult for investors to evaluate its historical performance or future prospects.
The company is highly dependent on its doctors and other healthcare professionals, as well as other key personnel and the loss of, or inability to attract or retain, such persons could adversely affect its business and results of operations.
The company is significantly dependent on its Promoters, Dr. Jaykumar Narendra Vyas, Dr. Shachi Jaykumar Vyas, and any loss of their services could adversely affect its business and results of operations.
Its operations are geographically located in Bharuch and Ankleshwar in Gujarat at present and any localized social unrest, natural calamities, etc. could have material adverse effect on business and financial operations.
The company is a boutique hospital, primarily provide services relating to interventional cardiac services. Any material impact on its earnings from these fields will impact the companys financial condition and results of operations significantly.
The company derives a significant portion of its revenues from its tie up arrangements with insurance companies, third party administrators and corporations. The loss of any one or more of its major customers would have a material effect on its business operations and profitability.
Delay in receipt of payment from its patients / customers may affect its cash flows, which may, in turn affect the companys financial condition and results of operations.
Its ability to provide affordable healthcare depends on the maintenance of a high volume of patients, occupancy rates, managing operating and effective capital management. Any increase in such costs could adversely affect its business, financial condition and results of operations.
Its failures to compete effectively against existing and new competitors, other multispecialty and/or super specialty hospitals and/or medical practitioners, could adversely affect its market share, business, financial condition, results of operations and prospects.
Its industry is highly regulated and requires it to obtain, renew and maintain statutory and regulatory permits, accreditations, licenses and comply with applicable safety, health, environmental, labour and other governmental regulations. Any regulatory changes or violations of such rules and regulations may adversely affect its business, financial condition and results of operations.
Investors | Holdings % |
Jaykumar Narendra Vyas | 86.72% |
Shachi Jaykumar Vyas | 0.02% |
Dhyuti Krupesh Joshi | 0% |
Organisation | Broach Lifecare Hospital Ltd |
Headquarters | Bharuch |
Industry | Healthcare |